Regulatory Binder: Maintaining Essential Study Documentation

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

CROMS NIDCR Clinical Monitoring
Tips to a Successful Monitoring Visit
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
HOT TOPICS ARCHIVING OR HOW NOT TO DUMP YOUR RUBBISH!
Managing Regulatory Documents Electronically
Research Coordination Guidance The Committees on Human Research Serving University of Vermont & Fletcher Allen Health Care
A Blueprint For Clinical Research: Standard Operating Procedures
Good Clinical Practice in Research
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
IRB 101: Introduction to Human Subject Research
Stanley Estime, MSCI December 9, 2014 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
Institutional Review Board (IRB) Human Subject Research Office (HSRO) University of Miami and Affiliated Institutions.
Overview of Good Clinical Practices (GCPs)
Who’s the Boss? Faculty Advisor or Principal Investigator Supervision versus Student Investigator or Study Coordinator Responsibilities Gwenn Snow, MS,
Recapture of Day 1 Suchart Chongprasert, Ph.D. Food and Drug Administration “Practical Aspects in Performing Clinical and Bioanalytical Parts in BA/BE.
Regulatory Authority Governing Clinical Trials Anthony J. Minisi, MD Director, Cardiology Fellowship Program.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
Common Audit Findings UTHSC Institutional Review Board (IRB)
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
The QA/QI Process Human Research Subjects Protection Human Investigation Committee Tracy Rightmer, JD, CIP Compliance Manager.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Changes Afloat at the Harvard LMA IRB: what you need to know for smooth sailing.
Leslie Howes, MPH, CIP Alyssa Speier, MS, CIP September 24, 2014 Investigator Manual: ra/investigator-manual/
Human Subjects Research Office of Responsible Research Practices Human Subjects Research Vanessa Hill, MSHS, CCRC Senior Quality Improvement Specialist.
Stanley Estime, MSCI October 19, 2015 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
The NCI Central IRB Initiative Jacquelyn L. Goldberg, J.D. VA IRB Chair Training April 8, 2004.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Office of Human Research Protection Georgia Health Sciences University.
Paul Hryvniak MS, CIP Alyssa Speier, MS, CIP September 30, 2014 Student Human Research Education Session Tel:
Stanley Estime, MSCI QA/QI Specialist January 17, 2013 Reportable New Information.
Good Clinical Practices and Best Research Practices at MU Health Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic.
IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
GCP (GOOD CLINICAL PRACTISE)
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
Responsibilities of Sponsor, Investigator and Monitor
Good Clinical Practice (GCP) and Monitoring Practices
Lisa Hoebelheinrich, JD, CHRC Associate Vice Chancellor, Compliance
The Role and Responsibilities of the Clinical Research Coordinator
Stephanie Oppenheimer, MS SUCCESS Center Erica Ellington, CRA, CHRC
Responsibilities of Sponsor, Investigator and Monitor
MAINTAINING THE INVESTIGATOR’S SITE FILE
IRB reporting updates.
Investigator of Record – Definition
Reportable Events & Other IRB Updates February 2017
Alyssa Speier, MS, CIP November 13, 2013
Reasons for Auditing There are many reasons for auditing. Some examples of these reasons might be: Requested by the IRB Committee Requested by an IRB.
Dining with Diabetes IRB Training 2017.
ESTR Basics for View-Only Users
REDCap Regulatory Binder
Elements of an Organized Regulatory Binder
Basics of Building and Understanding Data Collection Forms
What Every Harvard LMA Student Investigator Should Know
Investigator of Record – Definition
Investigator of Record – Definition
CONDUCTING THE TRIAL AT
What Every Harvard LMA Student Investigator Should Know
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Good Clinical Practice in Research
Demystifying the IRB Process: An Interactive Conversation with QIP
IRB Reporting Requirements & Reportable New Information (RNIs)
Understanding the Process of Documenting Informed Consent
CTSA27 So you want COMIRB to be your sIRB: What you need to know.
Senior Research Compliance Auditor
Good clinical practice
Presentation transcript:

Regulatory Binder: Maintaining Essential Study Documentation 11/12/2018 Regulatory Binder: Maintaining Essential Study Documentation

Regulatory Binder Based on ICH-GCP defined Essential Documents and OHRA’s Recordkeeping/Retention requirements ICH-GCP: International Conference on Harmonization – Good Clinical Practice Best Practice Standard Provides a template for maintaining and organizing documentation to ensure compliance with federal regulations, institutional policies, and good clinical practice Alternatives are acceptable. You can create your own way of organizing the required documentation in a way that works best for you and your study team. BE CONSISTENT!

Electronic Regulatory Binder (eBinder) The eBinders, developed in REDCap and Box.com, facilitate proper study management through electronic storage of study/regulatory documents and study management tools/logs. Instructions for institution-specific regulatory requirements, best practice recommendations, and GCP/Federal regulations are contained within each regulatory binder

Electronic Regulatory Binder (eBinder) The eBinders allows you to: Quickly download a custom template or utilize QIP’s template to customize your own binder to fit your study needs. Maintain regulatory documents for one or multiple studies. Securely share its contents with local and international study team members. How to access the binders: https://www.hsph.harvard.edu/ohra/quality-improvement-program-qip/study-management-tools/regulatory-binder/ Contains instructions for accessing our eBinder templates in REDCap and Box.com. Contact Stanley Estime to obtain access to the Box Template or if you have difficulty accessing REDCap’s eBinder.

Regulatory Binder Sections All Studies Study Specific Licensure Investigator Brochure/ Device Manual/ Package Insert Laboratory Documentation Drug/Device NIH Sponsor DSMB External/Local Ethical Review Protocol CVs for all study staff Logs IRB Documentation Consent and Recruitment Materials Data Collection Materials Training Data Protection

Essential Documents (all studies) Section Purpose Considerations / Recommendations Protocol Demonstrates investigator and/or sponsor agreement to the study aims, research design, research site(s), and all procedures, particularly those that involve human subjects. Ensure that the version number/date reflects the current, approved Research Protocol approved by the IRB. CVs and licensures Documents the qualifications and expertise of study staff to perform delegated tasks. CVs and licenses should be updated every 2 years to confirm that the information is current and accurate. CVs should be signed and dated Maintain licensure for staff conducting clinical study- related procedures

Essential Documents (all studies) Section Purpose Considerations / Recommendations Logs Assists with the collection of data that is required by or reported to the IRB or other regulatory authorities (e.g., Enrollment Log, Delegation of Responsibility Log). Information in QIP log templates can be customized to fit a specific study. IRB Documentation Demonstrates that the IRB has reviewed and approved the initial project and all modifications prior to the initiation of study procedures. Confirms that continuing review has been performed (as applicable) and that reportable new information has been communicated to the IRB. To simplify recordkeeping and avoid creating duplicate files, IRB documentation should be maintained in ESTR. Include a signed and dated note-to-file in the Regulatory Binder detailing the location of the documentation.

Essential Documents (all studies) Section Purpose Considerations / Recommendations Informed Consent Recruitment Material Documents that information given to participants supports their ability to give voluntary informed consent. Ensure that the most recently approved consent form and recruitment documents are used in the field. The most recently approved consent form and recruitment documents can always be accessed in ESTR. Data Collection Maintains original copies of all forms used to collect study data (e.g., case report forms, questionnaires, surveys). Only blank copies of forms should be kept in the Regulatory Binder. The most recently approved data collection forms can always be accessed in ESTR.

Essential Documents (all studies) Section Purpose Considerations / Recommendations Training Documents adequate human subjects training as well as any other study-specific training for all IRB approved study personnel. All study staff approved by the HLMA IRB must complete CITI human subjects training requirements every 3 years. Additional institution, department, or study-specific training requirements and time frames may vary (e.g., data security, laboratory safety). Data Protection Maintains documentation of data protection procedures not included in the Research Protocol, as well as specific records that may not be included in ESTR. For all documents maintained in ESTR, include a signed and dated note-to-file in the Regulatory Binder detailing the location of the documentation.

Participant Files Maintain participant files securely and separate from the Regulatory Binder Include original signed consent documents Depending on confidentiality provisions outlined in the Research Protocol, signed consent forms may be kept separate from the participant’s research data File completed data collection forms and source data Communication with participants As above, depending on confidentiality provisions outlined in the Research Protocol, communication that includes identifiers may be kept with signed consent documents and separate from research data

Single IRB and Multi-site Research 11/12/2018 Single IRB and Multi-site Research Include all institutional determinations and reliance agreements (SmartIRB or IRB Authorization Agreement and Institutional acknowledgments) in an External/Local Ethical Review file Regulatory documentation should reflect any reliance agreements The Overseeing IRB’s researchers should document up to date training and activities for all study staff that fall under the reviewing IRB’s oversight. Most reliance agreements allow for the reviewing institution to conduct an audit, for cause, of the ceding institution’s study documentation Regulatory documentation should still be kept at each institution to at least maintain site specific information. The protocol will determine how Participant Files should be maintained at each site.

Tips for Successful Record Keeping 11/12/2018 Tips for Successful Record Keeping Customize the Regulatory Binder to meet the specific criteria for your study Maintain binders in a secure location (e.g., locked file cabinet, password protected computer) Document and update materials in the Regulatory Binder in real time File hard copy documents in reverse chronological order (most recent on top)

Tips for Successful Record Keeping 11/12/2018 Tips for Successful Record Keeping Avoid maintaining duplicate records, particularly IRB documents (e.g., in ESTR, electronically on a shared drive, and hard copy in a paper-based Regulatory Binder) Review documentation routinely QIP recommends using the Investigator Self-Assessment as a guide when reviewing regulatory documentation Address and resolve documentation issues immediately upon discovery

Note-to-File A Note-to-File can reconcile many issues 11/12/2018 Note-to-File A Note-to-File can reconcile many issues When in doubt, write a note! Use to explain apparent discrepancies Use to identify location of files that are maintained outside of the Regulatory Binder (e.g., in electronic format on a shared drive or in ESTR) Each note-to-file should include the study number, PI name, date, and the initials of the person writing the note-to-file

Record Retention OHRA Policy: Maintain documentation for at least 7 years from study closure date The Regulatory Binder and study documents, including participant files, must be maintained securely and readily available to auditors Check with your sponsor to ensure compliance with their record retention policy

Resources OHRA web site Quality Improvement Program (QIP) web site 11/12/2018 Resources OHRA web site https://www.hsph.harvard.edu/ohra/ Quality Improvement Program (QIP) web site https://www.hsph.harvard.edu/ohra/qip/ QIP Study Management Tools - including Regulatory Binder tabs, Investigator Self-Assessment, and Note-to-File template https://www.hsph.harvard.edu/ohra/qip/study-management-tools/

OHRA Quality Improvement Program (QIP) Alyssa Speier, MS, CIP Associate Director, Office of Regulatory Affairs and Research Compliance aspeier@hsph.harvard.edu 617 432-2140 Lisa Gabel, CIP Senior QA/QI Specialist lgabel@hsph.harvard.edu 617 432-5842 Scott Meyers, CIP QA/QI Specialist scmeyers@hsph.harvard.edu 617 432-2143